Scientific Poster
May 23, 2016

Genomic Profiling of Late Stage Tumors Powering Precision Medicine in Japan

Genomic profiling of tumors provides patients with treatment options specific to their tumor’s biology.  Download this scientific poster presented at AACR 2016 Annual Meeting and learn how genomic profiling with Q2 Comprehensive Cancer Panel helps to inform treatment options for cancer patients in Japan.

Experts: Masashi Kanai1, Matthew Schu2, Tomohiro Sakuma3, Steven Abbott2, Tadayuki Kou1, Ross Gagnon2, Thomas Halsey2, Shigemi Matsumoto1, Mayumi Kamada4, Masahiko Nakatsui4, Yasushi Okuno4, Akinori Hiroshima3, Hiroaki Mochizuki3, Patrick Hurban2, Manabu Muto1, Victor J. Weigman, Jr.2 

Related Services: 1Dept. of Clinical Oncology, Kyoto University Hospital, Kyoto, Japan;
2EA Genomics, A Q2 Solutions Company, Morrisville, NC; 
3Biomedical Dept., Mitsui Knowledge Industry co., ltd, Toyko, Japan; 
4Department of Clinical System Onco-Informatics, Graduate School of Medicine, Kyoto University, Kyoto, Japan
Precision medicine: Shifting from one drug for all patients to personalized genomics-based therapeutic options

Gene expression for keeping pace with immuno-oncology breakthroughs and biomarker identification

When and how to use gene expression profiling

Read More